news
FDA grants accelerated approval for Leqembi
Alzheimer’s drug Leqembi has been accepted via the US Food…
Alzheimer’s drug Leqembi has been accepted via the US Food and Drug Administration (FDA)’s Accelerated Approval pathway.
List view / Grid view
Dr Billy Dunn
news
FDA grants accelerated approval for treatment of rare DMD mutation
The FDA has granted accelerated approval to Vyondys 53 for…
The FDA has granted accelerated approval to Vyondys 53 for the treatment of patients with Duchenne muscular dystrophy containing a mutation of the dystrophin gene that is amenable to exon 53 skipping.
news
FDA expands approval of Gilenya to treat multiple sclerosis in paediatric patients
The FDA has approved Gilenya to treat relapsing multiple sclerosis…
The FDA has approved Gilenya to treat relapsing multiple sclerosis in children and adolescents age 10 years and older...
